Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
Husam M. Salah, Subodh Verma, Carlos G. Santos‐Gallego, Ankeet S. Bhatt, Muthiah Vaduganathan, Muhammad Shahzeb Khan, Renato D. Lópes, Subhi J. Al’Aref, Darren K. McGuire, Marat Fudim
Topics & Concepts
EmpagliflozinHeart failureDapagliflozinEjection fractionMedicineInternal medicineVentricular remodelingCardiac function curveCardiologyAutophagyType 2 diabetesDiabetes mellitusEndocrinologyApoptosisBiologyBiochemistryDiabetes Treatment and ManagementPancreatic function and diabetesCardiovascular Function and Risk Factors